Burixafor is an investigational small molecule that blocks CXCL12 binding to CXCR4 receptors on HPCs, rapidly mobilizing these cells from the bone marrow into the peripheral blood. In preclinical ...
Money Talks News on MSN
Heart pills become women's secret weapon for anxiety
Celebrity endorsements drive propranolol trend among women seeking non-addictive anxiety relief, though FDA hasn't approved ...
According to the data presented at the American Society of Hematology Annual Meeting, 17 of 19 participants (89.5%) successfully collected the required number of CD34+ cells within two leukapheresis ...
Exicure (XCUR) announced results from its completed Phase 2 trial evaluating burixafor in combination with propranolol and granulocyte colony-stimulating factor for the mobilization of hematopoietic ...
Praxis confirms plans to submit the essential tremor NDA for ulixacaltamide in early 2026BOSTON, Dec. 04, 2025 (GLOBE ...
The heart medication can ease physical symptoms of panic, making them popular for job interviews, public speaking events and ...
The Ministry of Food and Drug Safety ordered recalls after impurities, label errors, and packaging problems were found in some medicines made by pharmaceutical companies including Daewon ...
HACKENSACK, N.J., Nov. 21, 2025 /PRNewswire/ — Investigators from Hackensack Meridian John Theurer Cancer Center (JTCC)—a leading research partner of the NCI-designated Lombardi Comprehensive Cancer ...
Mounjaro’s typical starting dosage is 2.5 milligrams (mg) once per week for 4 weeks, after which your doctor may increase the dose to 5 mg per week if needed to manage blood sugar levels. The ...
solution in a single-use Sensoready pen solution in a single-use UnoReady pen solution in a single-use prefilled syringe Cosentyx also comes as a solution in a single-use vial that’s given as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback